New Year’s Message from LRA President & CEO Albert Roy

NEW YEAR’S MESSAGE FROM
LRA PRESIDENT & CEOLRA introduces 2022 Distinguised Innovator Award RecipientsAs we welcome in the new year, hear from Lupus Research Alliance President & CEO Albert Roy how 2022 was a time of remarkable progress and why 2023 holds tremendous promise for lupus discovery and treatment advances.Al’s recap of last year’s accomplishments demonstrates how the LRA and our clinical research affiliate Lupus Therapeutics are making a profound difference for our community and inspires renewed hope for life without lupus!

Facebook Twitter

Recent Stories & News

News Update
LRA Spotlight on ACR Convergence 2024: Lupus Therapeutics-Supported Clinical Research and More
November 21, 2024 — The Lupus Research Alliance and clinical research affiliate, Lupus Therapeutics, are excited to present highlights of...
News Update
News from ACR Convergence 2024
ACR Released a Summary of the 2024 ACR Guideline for the Screening, Treatment, and Management of Lupus Nephritis
November 18, 2024 — The American College of Rheumatology (ACR) released a summary of the 2024 ACR Guideline for the Screening,...
Story
Celebrating Native American Heritage Month: Meet Dr. Kent Kwoh, A Champion for Health Equity
November 14, 2024 — During Native American Heritage Month, we celebrate a dedicated champion of health equity. As Chief of Rheumatology...